Astera Labs looks relatively expensive because similarly fast-growing AI infrastructure names trade at much lower multiples. Broadcom and Nvidia are at 14x, Credo at 15x and Lumentum at 18x; comparable peers look 50-80% cheaper. Astera is a great company and not necessarily expensive in absolute terms. Its roughly 2x multiple over Credo may persist, but the setup looks harder; with no valuation support, it could fall 50% if weakness continues. x.com  x.com  x.com  x.com 

Credo is a trade rather than a long-term hold because co-packaged optics is the technology that closes the copper-to-optics gap its retimers and active electrical cables fill. If CPO ramps faster than expected in the 2027 architecture cycle, those products get designed out. That is not a 2026 problem, but it is why a decelerating hyper-growth chipmaker can't keep a 15x sales multiple forever. Customer concentration, which hit the stock before, adds risk, and Credo fits no AI endgame theme. x.com  … Show more

Credo's near-total share of AI data-center cables and unchanged estimates make its lower multiple look like a fear-driven opportunity. Its stock went from 27x to 20x forward earnings while the supply chain building those systems guided 2027 revenue to double. Buyers this week will probably be very happy a year from now. x.com 

Credo's 11% drop on its promotion to the Russell 1000 was index plumbing, but falling twice as much as chips exposed its fragility: at 33x sales with three customers making up 88% of revenue, it is vulnerable. Forced Russell 2000 selling met only a teaspoon of large-cap index buying. Holding $236 and reclaiming $241 targets a $252 gap fill; losing $231 means real sellers. The next print, around early September, decides it: falling concentration makes it a trade, 88% staying means fade the rip. … Show more

Credo's results were underwhelming for a company that added $32 billion in market value in a few months, and shorts may punish the stock. Per @WisemanCap, fiscal Q4 EPS of $1.16 beat the $1.02 estimate and revenue of $437 million was just above estimates, while Q1 fiscal 2027 revenue guidance of $465-476 million was roughly in line with the $464.7 million consensus. x.com  x.com 

MaxLinear's planned 1.6T AEC entry is too distant to justify the scale of Credo's selloff. Credo still has an estimated 90%+ AEC share and relationships with five of six major hyperscalers; MaxLinear expects initial revenue only in 2027 and a more meaningful ramp in 2028. Competition bears watching, but the market looks to be overreacting and Credo is starting to look ridiculously cheap. x.com  x.com 

Ciena's stronger moat justifies its richer valuation versus Credo, and its recent guidance was good. x.com 

Credo's upside looks capped as growth falls short of earlier expectations and large stock-based compensation, hidden behind GAAP financials, looks excessive. BofA cut its target to $275 from $340 and Evercore to $292 from $325 on deceleration worries, the 1.6T DSP is delayed, and operating cash flow fell to $90M. The stock is 43% off its high; at $164 it trades at 30-33x FY27 earnings and 13x forward sales, more reasonable but still not worth owning. x.com  x.com  x.com  x.com 

Credo's leading AEC position and vertical integration keep its optics thesis bullish despite SpaceX moving away from 1.6T AECs. That shift is a genuine risk, but xAI has been in Credo's AEC ecosystem the longest, which could support ZeroFlap optics and its telemetry software. Credo's VCSEL-based ALCs were still ramping toward 2027, giving it another route as customers move to transceivers. x.com  x.com  x.com 

Cerebras looks cheap if it can grow revenue tenfold over three years, though expensive on 2026 numbers. Its 15% after-hours drop looks unwarranted after it raised full-year guidance and gross margins, and management expects gross margins to rise from 40% to 60%, implying EBITDA margins of 40% or more. At about $50 billion with almost $9 billion of cash, $10 billion of 2029 revenue could make it a 3-bagger in three years, but it is a riskier story with serious customer concentration. x.com  x.com  … Show more